These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27303208)

  • 1. Toxic Epidermal Necrolysis Induced by the Topical Carbonic Anhydrase Inhibitors Brinzolamide and Dorzolamide.
    Chun JS; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    Ann Dermatol; 2008 Dec; 20(4):260-2. PubMed ID: 27303208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
    Cvetkovic RS; Perry CM
    Drugs Aging; 2003; 20(12):919-47. PubMed ID: 14565787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical overview of brinzolamide.
    DeSantis L
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S119-29. PubMed ID: 10665514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors.
    Sugrue MF
    Prog Retin Eye Res; 2000 Jan; 19(1):87-112. PubMed ID: 10614682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
    Gugleta K
    Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Silver LH
    Am J Ophthalmol; 1998 Sep; 126(3):400-8. PubMed ID: 9744373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' acceptance of a switch from dorzolamide to brinzolamide for the treatment of glaucoma in a clinical practice setting.
    Barnebey H; Kwok SY
    Clin Ther; 2000 Oct; 22(10):1204-12. PubMed ID: 11110231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of intraocular-pressure- lowering efficacy and side effects of 2% dorzolamide and 1% brinzolamide.
    Seong GJ; Lee SC; Lee JH; Chu YK; Hong YJ
    Ophthalmologica; 2001; 215(3):188-91. PubMed ID: 11340389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF; Krupin T; Tang LQ; Hong PH; Ruderman JM
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of brinzolamide 1% ophthalmic suspension (Azopt) as a primary therapy in patients with open-angle glaucoma or ocular hypertension. Brinzolamide Primary Therapy Study Group.
    Sall K
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S155-62. PubMed ID: 10665518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of adverse events in self-reported sulfa-allergic patients using topical carbonic anhydrase inhibitors.
    Guedes GB; Karan A; Mayer HR; Shields MB
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):456-61. PubMed ID: 23445203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of α2-adrenergic agonists versus carbonic anhydrase inhibitors as adjunctive therapy.
    Cheng JW; Cheng SW; Yu DY; Wei RL; Lu GC
    Curr Med Res Opin; 2012 Apr; 28(4):543-50. PubMed ID: 22321008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dorzolamide-induced relaxation of intraocular porcine ciliary arteries in vitro depends on nitric oxide and the vascular endothelium.
    Kringelholt S; Simonsen U; Bek T
    Curr Eye Res; 2012 Dec; 37(12):1107-13. PubMed ID: 22816608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives.
    Lo Faro AF; Tini A; Bambagiotti G; Pirani F; Faragalli A; Carle F; Pacella E; Ceka A; Moretti M; Gottardi M; Lassandro NV; Nicolai M; Lupidi M; Mariotti C; Busardò FP; Carlier J
    Biology (Basel); 2022 Sep; 11(10):. PubMed ID: 36290285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X; Ilies M; Casini A; Dogné JM; Scozzafava A; Masini E; Mincione F; Starnotti M; Supuran CT
    J Med Chem; 2004 May; 47(11):2796-804. PubMed ID: 15139757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor.
    Wilkerson M; Cyrlin M; Lippa EA; Esposito D; Deasy D; Panebianco D; Fazio R; Yablonski M; Shields MB
    Arch Ophthalmol; 1993 Oct; 111(10):1343-50. PubMed ID: 8216014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of brinzolamide and dorzolamide on aqueous humor flow in human eyes.
    Ingram CJ; Brubaker RF
    Am J Ophthalmol; 1999 Sep; 128(3):292-6. PubMed ID: 10511022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Switching from systemic to the topical carbonic anhydrase inhibitor dorzolamide: effect on the quality of life of glaucoma patients with drug-related side effects.
    Nesher R; Ticho U
    Isr Med Assoc J; 2003 Apr; 5(4):260-3. PubMed ID: 14509130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased optic nerve head blood flow after 1 week of twice daily topical brinzolamide treatment in Dutch-belted rabbits.
    Barnes GE; Li B; Dean T; Chandler ML
    Surv Ophthalmol; 2000 Jan; 44 Suppl 2():S131-40. PubMed ID: 10665515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.